陽電子放出断層撮影（PET）の世界市場の評価：製品別、検出器別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

世界の陽電子放出断層撮影（PET）の市場規模は、2023年の17億米ドルから2031年に25億8,000万米ドルに達し、予測期間の2024年～2031年にCAGRで5.1%の成長が見込まれています。市場は、心臓病、脳卒中、がんなどの慢性疾患の増加の影響を受けています。このような慢性疾患の急増は、その精度と早期発見能力で知られるPETスキャンのような先進の診断ツールに対する需要を高めています。もう1つの重要な促進要因には、解像度の向上や高速スキャン能力などの技術の進歩があり、これにより複雑な手技でも正確なイメージングが可能になり、最終的に診断精度と患者の転帰が向上します。さらに、ハイブリッドPET/CTやPET/MRIシステムの導入は、臨床現場におけるPETスキャンの有効性を多様化および強化し、市場成長を促進しています。

政府の取り組みと資金提供も、広範な研究開発（R&D）、インフラの拡大、償還政策を通じて世界の陽電子放出断層撮影（PET）市場を牽引しています。産業内での投資やパートナーシップの増加とともに、こうした取り組みが技術革新を促し、PET技術の進化を促進しています。加えて、老年人口の急増により、加齢に関連した疾病が流行するようになり、PET検査の需要が増加しています。PETイメージングの認知と受容の高まりは、神経学や循環器学などの分野への拡大とともに、診断ツールとしての極めて重要な役割をさらに確固たるものにしています。

拡大するPETスキャンの応用

陽電子放出断層撮影（PET）イメージングの応用範囲の拡大は、市場拡大の大きな促進要因となっています。当初は腫瘍診断における優位性が認識されていたPETイメージングですが、現在では神経学や循環器学など多様な医療領域に広がっています。PET技術の進化と新たな放射性トレーサーの開発により、PETの有用性は拡大し続けており、医療従事者は疾病メカニズム、治療反応、個別化医療アプローチをより深く掘り下げることができます。このような応用の増加は、患者の治療水準を向上させるだけでなく、PETイメージングシステムに対する需要を増加させ、世界のPET市場の普及と継続的な成長に大きく寄与しています。さらに、装置の感度を最大化することで用量を減らし、より迅速な診断を提供することができるため、医療領域全体でPETスキャンの応用が拡大します。

研究施設の設立

新しい研究施設の設立は、世界の陽電子放出断層撮影（PET）市場の主な促進要因です。これらのセンターは技術革新の拠点として機能し、最先端のPETイメージング技術、放射性トレーサー、手法の進歩を育んでいます。これらのセンターは共同研究を促進し、さまざまな医療応用の研究を支援し、さまざまな病態の診断や追跡におけるPETの有効性を向上させるのに役立っています。このような取り組みは、投資や共同研究を呼び込むだけでなく、PET技術の開発を促進し、医療に対する影響力を増大させます。このプロセスは市場の拡大を刺激し、診断能力の継続的な進歩を保証します。

例えば、2023年12月12日にAustralian National Total Body PET Facilityが設立されました。この施設は、がん研究、神経疾患、心血管疾患研究、医薬品開発などの進歩を促進します。この施設の導入は、スキャン時間と放出線被曝を最小限に抑え、患者ケアの基準を革新することを目指しています。

政府の取り組み

世界の各国の政府は、世界の陽電子放出断層撮影（PET）市場の進歩を促進する戦略を積極的に実施しています。これらの戦略には、研究への資金援助、技術の進歩の促進、PET技術の利用可能性の向上が含まれます。研究開発を支援することで、政府はPETイメージングの進化を促し、先進のイメージングシステムや革新的な放射性トレーサーの開発を育成しています。さらに、償還政策や医療インフラを改善する取り組みは、PETスキャンの採用を促進する上で大きな役割を果たしています。このような政府の広範な取り組みは、PET市場を強化し、その拡大を促進し、現代の診断医療における不可欠な役割を強化することを目的としています。

当レポートでは、世界の陽電子放出断層撮影（PET）市場について調査分析し、市場規模と予測、市場力学、主要企業情勢と見通しなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 世界の陽電子放出断層撮影（PET）市場の見通し

第4章 エグゼクティブサマリー

第5章 世界の陽電子放出断層撮影（PET）市場の見通し（2017年～2031年）

• 市場規模と予測
  • 金額
  • 数量
• 製品別
  • デバイス
  • プラットフォーム/ソフトウェア
• 検出器別
  • シリコン光電子増倍管（SiPM）
  • デジタルフォトンカウンター（DPC）
  • オキシオルトケイ酸ルテチウム（LSO）
  • オルトケイ酸ルテチウムイットリウム（LYSO）
  • その他
• 用途別
  • 神経
  • 腫瘍
  • 心血管
  • その他
• エンドユーザー別
  • 病院
  • 診断・イメージングクリニック
  • その他
• 地域別
  • 北米
  • 欧州
  • 南米
  • アジア太平洋
  • 中東・アフリカ
• 市場シェア：企業別（2023年）

第6章 世界の陽電子放出断層撮影（PET）市場の見通し：地域別（2017年～2031年）

• 北米
  • 製品別
  • 検出器別
  • 用途別
  • エンドユーザー別
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • フランス
  • イタリア
  • 英国
  • ロシア
  • オランダ
  • スペイン
  • トルコ
  • ポーランド
• 南米
  • ブラジル
  • アルゼンチン
• アジア太平洋
  • インド
  • 中国
  • 日本
  • オーストラリア
  • ベトナム
  • 韓国
  • インドネシア
  • フィリピン
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • 南アフリカ

第7章 市場マッピング（2023年）

• 製品別
• 検出器別
• 用途別
• エンドユーザー別
• 地域別

第8章 マクロ環境と産業構造

• 需給分析
• 輸出入の分析
• バリューチェーン分析
• PESTEL分析
• ポーターのファイブフォース分析

第9章 市場力学

• 成長促進要因
• 成長抑制要因（課題、抑制要因）

第10章 規制枠組みとイノベーション

• 臨床試験
• 特許情勢
• 規制当局の承認
• イノベーション/新技術

第11章 主要企業情勢

• マーケットリーダー上位5社の競合マトリクス
• マーケットリーダー上位5社の市場収益分析（2023年）
• 合併と買収/合弁事業（該当する場合）
• SWOT分析（市場参入企業5社）
• 特許分析（該当する場合）

第12章 価格分析

第13章 ケーススタディ

第14章 主要企業の見通し

• GE Healthcare
• Fujifilm Holdings Corporation
• Siemens Healthineers Corporation
• Canon Medical Systems Corporation
• Neusoft Corporation
• Shimadzu Corporation
• CMR Naviscan
• Mediso Ltd.
• Koninklijke Philips N.V.
• Yangzhou Kindsway Biotech Co. Ltd.
• Shanghai United Imaging Healthcare Co Ltd.
• Positron Corporation

第15章 戦略的推奨事項

第16章 当社について、免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Global Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 2. Global Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 3. Global Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 4. Global Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 5. Global Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 6. Global Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 7. Global Positron Emission Tomography Market Share (%), By Region, 2017-2031F
• Figure 8. North America Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 9. North America Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 10. North America Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 11. North America Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 12. North America Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 13. North America Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 14. North America Positron Emission Tomography Market Share (%), By Country, 2017-2031F
• Figure 15. United States Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 16. United States Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 17. United States Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 18. United States Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 19. United States Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 20. United States Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 21. Canada Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 22. Canada Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 23. Canada Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 24. Canada Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 25. Canada Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 26. Canada Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 27. Mexico Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 28. Mexico Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 29. Mexico Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 30. Mexico Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 31. Mexico Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 32. Mexico Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 33. Europe Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 34. Europe Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 35. Europe Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 36. Europe Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 37. Europe Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 38. Europe Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 39. Europe Positron Emission Tomography Market Share (%), By Country, 2017-2031F
• Figure 40. Germany Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 41. Germany Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 42. Germany Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 43. Germany Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 44. Germany Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 45. Germany Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 46. France Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 47. France Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 48. France Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 49. France Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 50. France Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 51. France Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 52. Italy Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 53. Italy Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 54. Italy Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 55. Italy Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 56. Italy Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 57. Italy Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 58. United Kingdom Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 59. United Kingdom Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 60. United Kingdom Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 61. United Kingdom Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 62. United Kingdom Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 63. United Kingdom Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 64. Russia Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 65. Russia Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 66. Russia Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 67. Russia Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 68. Russia Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 69. Russia Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 70. Netherlands Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 71. Netherlands Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 72. Netherlands Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 73. Netherlands Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 74. Netherlands Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 75. Netherlands Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 76. Spain Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 77. Spain Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 78. Spain Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 79. Spain Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 80. Spain Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 81. Spain Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 82. Turkey Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 83. Turkey Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 84. Turkey Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 85. Turkey Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 86. Turkey Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 87. Turkey Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 88. Poland Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 89. Poland Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 90. Poland Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 91. Poland Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 92. Poland Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 93. Poland Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 94. South America Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 95. South America Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 96. South America Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 97. South America Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 98. South America Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 99. South America Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 100. South America Positron Emission Tomography Market Share (%), By Country, 2017-2031F
• Figure 101. Brazil Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 102. Brazil Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 103. Brazil Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 104. Brazil Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 105. Brazil Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 106. Brazil Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 107. Argentina Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 108. Argentina Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 109. Argentina Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 110. Argentina Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 111. Argentina Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 112. Argentina Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 113. Asia-Pacific Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 114. Asia-Pacific Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 115. Asia-Pacific Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 116. Asia-Pacific Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 117. Asia-Pacific Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 118. Asia-Pacific Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 119. Asia-Pacific Positron Emission Tomography Market Share (%), By Country, 2017-2031F
• Figure 120. India Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 121. India Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 122. India Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 123. India Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 124. India Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 125. India Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 126. China Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 127. China Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 128. China Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 129. China Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 130. China Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 131. China Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 132. Japan Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 133. Japan Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 134. Japan Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 135. Japan Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 136. Japan Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 137. Japan Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 138. Australia Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 139. Australia Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 140. Australia Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 141. Australia Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 142. Australia Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 143. Australia Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 144. Vietnam Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 145. Vietnam Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 146. Vietnam Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 147. Vietnam Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 148. Vietnam Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 149. Vietnam Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 150. South Korea Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 151. South Korea Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 152. South Korea Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 153. South Korea Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 154. South Korea Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 155. South Korea Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 156. Indonesia Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 157. Indonesia Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 158. Indonesia Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 159. Indonesia Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 160. Indonesia Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 161. Indonesia Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 162. Philippines Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 163. Philippines Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 164. Philippines Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 165. Philippines Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 166. Philippines Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 167. Philippines Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 168. Middle East & Africa Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 169. Middle East & Africa Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 170. Middle East & Africa Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 171. Middle East & Africa Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 172. Middle East & Africa Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 173. Middle East & Africa Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 174. Middle East & Africa Positron Emission Tomography Market Share (%), By Country, 2017-2031F
• Figure 175. Saudi Arabia Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 176. Saudi Arabia Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 177. Saudi Arabia Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 178. Saudi Arabia Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 179. Saudi Arabia Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 180. Saudi Arabia Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 181. UAE Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 182. UAE Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 183. UAE Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 184. UAE Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 185. UAE Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 186. UAE Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 187. South Africa Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
• Figure 188. South Africa Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
• Figure 189. South Africa Positron Emission Tomography Market Share (%), By Product, 2017-2031F
• Figure 190. South Africa Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
• Figure 191. South Africa Positron Emission Tomography Market Share (%), By Application, 2017-2031F
• Figure 192. South Africa Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
• Figure 193. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 194. By Detector Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 195. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Global positron emission tomography market is projected to witness a CAGR of 5.1% during the forecast period 2024-2031, growing from USD 1.7 billion in 2023 to USD 2.58 billion in 2031. The global positron emission tomography market is being influenced by the increasing prevalence of chronic diseases such as heart diseases, stroke, and cancer. This surge in chronic diseases is increasing the demand for advanced diagnostic tools like PET scans, known for their precision and early detection capabilities. Another important driver include technological advancements, such as increased resolution and fast scanning abilities, which enable precise imaging for complicated procedures, ultimately enhancing diagnostic precision and patient outcomes. Moreover, the introduction of hybrid PET/CT and PET/MRI systems have diversified and enhanced the effectiveness of PET scans in clinical settings, thereby propelling the growth of global positron emission tomography market.

Government initiatives and funding are also driving the global positron emission tomography market through extensive research and development (R&D), expansion in infrastructure, and reimbursement policies. Combined with increased investments and partnerships within the industry, these efforts encourage innovation and propel PET technology's evolution. Additionally, a burgeoning elderly population is increasing the demand for PET scans as age-related ailments become more prevalent. Growing recognition and acceptance of PET imaging, along with its expansion into fields like neurology and cardiology, is further solidifying its pivotal role as a diagnostic tool.

Growing Application of PET Scans

The growing scope of positron emission tomography (PET) imaging applications significantly drives the market expansion. Initially recognized for its dominance in oncology diagnostics, PET imaging now spans diverse medical domains like neurology and cardiology. With the evolution of PET technology and the development of novel radiotracers, its utility continues to grow, empowering healthcare experts to delve deeper into disease mechanisms, treatment responses, and personalized medical approaches. This increased array of applications not only elevates patient care standards, but also increases the demand for PET imaging systems, thus significantly contributing to the widespread adoption and continuous growth of the global positron emission tomography market. In addition, the device's maximized sensitivity can be used to reduce the dosage and offer faster diagnosis, which will expand the application of PET scans across the healthcare domain.

Establishment of Research Facilities

The establishment of new research facilities is a key driving factor for the global positron emission tomography market. These centers act as innovation hubs, nurturing the advancement of cutting-edge PET imaging technologies, radiotracers, and methods. They facilitate joint research endeavors, support the exploration of various medical applications, and help improve PET's effectiveness in diagnosing and tracking different conditions. These initiatives not only draw investments and collaborations, but also expedite the development of PET technology, amplifying its influence on healthcare. This process stimulates market expansion and guarantees ongoing progress in diagnostic capabilities.

For example, the establishment of The Australian National Total Body PET Facility occurred on December 12th, 2023. Marking Australia's inaugural total body PET scanner available for unrestricted research use, this facility is poised to propel progress in cancer research, neurological disorders, cardiovascular disease studies, and pharmaceutical development. Its implementation aims to minimize scanning durations and radiation exposure, thereby revolutionizing patient care standards.

Government Initiatives

Governments around the globe are proactively implementing strategies to drive the advancement of the global positron emission tomography market. These strategies involve financing research, promoting technological progress, and improving the availability of PET technology. By supporting R&D, governments encourage the evolution of PET imaging, nurturing the development of advanced imaging systems and innovative radiotracers. Moreover, initiatives to improve reimbursement policies and healthcare infrastructure play a major role in driving the adoption of PET scan. These extensive government initiatives aim to strengthen the PET market, fostering its expansion and reinforcing its essential role in contemporary diagnostic medicine.

For instance, in November 2023, as a part of the Chief Minister's Comprehensive Health Insurance Scheme, Coimbatore Medical College Hospital (CMCH) received a boost with the commissioning of a PET CT (Positron emission tomography and computed tomography) scan machine worth INR 12 crore. At the CMCH, the procedure, which would have cost INR 20,000 in private hospitals, would only cost INR 6,500 to INR 11,000, with the Chief Minister's insurance plan covering the cost.

Increasing Use of PET Scan in Oncology

The use of PET in oncology is significantly driving the global market. PET imaging's accuracy in identifying and tracking cancerous developments supports early detection, precise staging, and evaluation of treatment response. Its capacity to offer comprehensive metabolic insights into tumors aids oncologists in making informed decisions. As PET technology advances persistently and new radiotracers emerge, its role in oncology is also growing. This progression not only enhances patient results, but also substantially bolsters the global adoption and growth of PET technology.

For instance, Meilleur Technologies, Inc. unveiled a research collaboration pact with the Young Blood Institute (YBI) on exploring the application of Meilleur's [F-18]NAV-4694, an investigative imaging agent, in positron emission tomography examinations. This device is designed to evaluate the presence of amyloid plaque within the brain. Amyloid plaques signify a prominent feature across various neurodegenerative conditions, notably Alzheimer's disease.

Advanced Software Solutions in Positron Emission Tomography

The increasing demand for PET software solutions is acting as a driving force behind the expansion of the global positron emission tomography market. With healthcare institutions progressively depending on PET imaging for precise disease diagnosis and monitoring treatments, there's a growing requirement for advanced software that improves image processing, analysis, and interpretation. Advanced PET software enhances workflow efficiency, facilitates precise data analysis, and improves the integration of PET scans with other imaging methods. This increased demand not only enhances the effectiveness of PET technology, but also contributes to market growth by meeting the changing demands of healthcare practitioners to deliver enhanced patient care.

For example, in May 2023, Precision DL (GE HealthCare), an AI-driven image processing software, received 510(k) clearance from the Food and Drug Administration (FDA). This software is anticipated to deliver notable enhancements in contrast-to-noise ratio (CNR), precision in quantifying features, and the ability to diagnose small lesions in PET scans.

Future Market Scenario (2024-2031F)

The future of the global positron emission tomography market exhibits remarkable promise, poised for substantial expansion. Various factors are contributing to this positive projection. Advancements in PET technology, encompassing enhanced imaging resolution, faster scan speeds, and the creation of novel radiotracers are expanding PET scan applications with increased accuracy. Furthermore, the surge in chronic diseases worldwide, alongside a growing elderly population, is increasing the demand for precise diagnostic tools like PET scans. Additionally, PET's diversified usage spanning beyond oncology into segments like neurology, cardiology, and psychiatric disorders solidifies its significance in healthcare diagnostics. Collaborative endeavors between public and private sectors, reinforced by supportive government measures and improved reimbursement policies, foster market growth. Besides this, ongoing research and technological advancements are expected to position the global positron emission tomography market for notable progress and evolution in the coming years.

Key Players Landscape and Outlook

Key global positron emission tomography market players are establishing strategic alliances. These partnerships among leading firms seek to combine resources, knowledge, and technologies, aiming to propel advancements in PET imaging. These collaborations focus on stimulating innovation, creating state-of-the-art PET systems, and pioneering new radiotracers. Such affiliations enable the integration of diverse strengths, fostering research and expediting the introduction of advanced PET solutions. Ultimately, these initiatives are driving the market's progression, ensuring refined diagnostic accuracy and substantially contributing to PET technology's global growth and progression.

In September 2023, Jubilant DraxImage Inc., operating as Jubilant Radiopharma, a wholly owned subsidiary of Jubilant Pharma Limited, initiated an exclusive collaboration with Cardiac Imaging, Inc. in Oakbrook Terrace, Illinois. The partnership aims to offer healthcare facilities a daily-leased rubidium solution for conducting cardiac PET scans, thereby enhancing access to cutting-edge cardiac PET imaging for patients suspected of coronary artery disease (CAD).

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Outlook of Global Positron Emission Tomography Market

4. Executive Summary

5. Global Positron Emission Tomography Market Outlook, 2017-2031F

• 5.1. Market Size & Forecast
  • 5.1.1. Value
  • 5.1.2. Volume
• 5.2. By Product
  • 5.2.1. Device
    • 5.2.1.1. Full Ring PET Scanners
    • 5.2.1.2. Partial Ring PET Scanners
  • 5.2.2. Platform/Software
• 5.3. By Detector
  • 5.3.1. Silicon Photomultiplier (SiPM)
  • 5.3.2. Digital Photon Counters (DPC)
  • 5.3.3. Lutetium Oxyorthosilicate (LSO)
  • 5.3.4. Lutetium Yttrium Orthosilicate (LYSO)
  • 5.3.5. Others
• 5.4. By Application
  • 5.4.1. Neurology
  • 5.4.2. Oncology
  • 5.4.3. Cardiovascular
  • 5.4.4. Others
• 5.5. By End-user
  • 5.5.1. Hospitals
  • 5.5.2. Diagnostic & Imaging Clinics
  • 5.5.3. Others
• 5.6. By Region
  • 5.6.1. North America
  • 5.6.2. Europe
  • 5.6.3. South America
  • 5.6.4. Asia-Pacific
  • 5.6.5. Middle East and Africa
• 5.7. By Company Market Share (%), 2023

6. Global Positron Emission Tomography Market Outlook, By Region, 2017-2031F

• 6.1. North America*
  • 6.1.1. By Product
    • 6.1.1.1. Device
    • 6.1.1.1.1. Full Ring PET Scanners
    • 6.1.1.1.2. Partial Ring PET Scanners
    • 6.1.1.2. Platform/Software
  • 6.1.2. By Detector
    • 6.1.2.1. Silicon Photomultiplier (SiPM)
    • 6.1.2.2. Digital Photon Counters (DPC)
    • 6.1.2.3. Lutetium Oxyorthosilicate (LSO)
    • 6.1.2.4. Lutetium Yttrium Orthosilicate (LYSO)
    • 6.1.2.5. Others
  • 6.1.3. By Application
    • 6.1.3.1. Neurology
    • 6.1.3.2. Oncology
    • 6.1.3.3. Cardiovascular
    • 6.1.3.4. Others
  • 6.1.4. By End-user
    • 6.1.4.1. Hospitals
    • 6.1.4.2. Diagnostic & Imaging Clinics
    • 6.1.4.3. Others
  • 6.1.5. United States*
    • 6.1.5.1. By Product
    • 6.1.5.1.1. Device
    • 6.1.5.1.1.1. Full Ring PET Scanners
    • 6.1.5.1.1.2. Partial Ring PET Scanners
    • 6.1.5.1.2. Platform/Software
    • 6.1.5.2. By Detector
    • 6.1.5.2.1. Silicon Photomultiplier (SiPM)
    • 6.1.5.2.2. Digital Photon Counters (DPC)
    • 6.1.5.2.3. Lutetium Oxyorthosilicate (LSO)
    • 6.1.5.2.4. Lutetium Yttrium Orthosilicate (LYSO)
    • 6.1.5.2.5. Others
    • 6.1.5.3. By Application
    • 6.1.5.3.1. Neurology
    • 6.1.5.3.2. Oncology
    • 6.1.5.3.3. Cardiovascular
    • 6.1.5.3.4. Others
    • 6.1.5.4. By End-user
    • 6.1.5.4.1. Hospitals
    • 6.1.5.4.2. Diagnostic & Imaging Clinics
    • 6.1.5.4.3. Others
  • 6.1.6. Canada
  • 6.1.7. Mexico

All segments will be provided for all regions and countries covered

• 6.2. Europe
  • 6.2.1 Germany
  • 6.2.2 France
  • 6.2.3 Italy
  • 6.2.4 United Kingdom
  • 6.2.5 Russia
  • 6.2.6 Netherlands
  • 6.2.7 Spain
  • 6.2.8 Turkey
  • 6.2.9 Poland
• 6.3. South America
  • 6.3.1. Brazil
  • 6.3.2. Argentina
• 6.4. Asia-Pacific
  • 6.4.1. India
  • 6.4.2. China
  • 6.4.3. Japan
  • 6.4.4. Australia
  • 6.4.5. Vietnam
  • 6.4.6. South Korea
  • 6.4.7. Indonesia
  • 6.4.8. Philippines
• 6.5. Middle East & Africa
  • 6.5.1. Saudi Arabia
  • 6.5.2. UAE
  • 6.5.3. South Africa

7. Market Mapping, 2023

• 7.1. By Product
• 7.2. By Detector
• 7.3. By Application
• 7.4. By End-user
• 7.5. By Region

8. Macro Environment and Industry Structure

• 8.1. Supply Demand Analysis
• 8.2. Import Export Analysis
• 8.3. Value Chain Analysis
• 8.4. PESTEL Analysis
  • 8.4.1. Political Factors
  • 8.4.2. Economic System
  • 8.4.3. Social Implications
  • 8.4.4. Technological Advancements
  • 8.4.5. Environmental Impacts
  • 8.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 8.5. Porter's Five Forces Analysis
  • 8.5.1. Supplier Power
  • 8.5.2. Buyer Power
  • 8.5.3. Substitution Threat
  • 8.5.4. Threat from New Entrant
  • 8.5.5. Competitive Rivalry

9. Market Dynamics

• 9.1. Growth Drivers
• 9.2. Growth Inhibitors (Challenges and Restraints)

10. Regulatory Framework and Innovation

• 10.1 Clinical Trials
• 10.2 Patent Landscape
• 10.3 Regulatory Approvals
• 10.4 Innovations/Emerging Technologies

11. Key Players Landscape

• 11.1. Competition Matrix of Top Five Market Leaders
• 11.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
• 11.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
• 11.4. SWOT Analysis (For Five Market Players)
• 11.5. Patent Analysis (If Applicable)

12. Pricing Analysis

13. Case Studies

14. Key Players Outlook

• 14.1. GE Healthcare
  • 14.1.1. Company Details
  • 14.1.2. Key Management Personnel
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As reported)
  • 14.1.5. Key Market Focus & Geographical Presence
  • 14.1.6. Recent Developments
• 14.2. Fujifilm Holdings Corporation
• 14.3. Siemens Healthineers Corporation
• 14.4. Canon Medical Systems Corporation
• 14.5. Neusoft Corporation
• 14.6. Shimadzu Corporation
• 14.7. CMR Naviscan
• 14.8. Mediso Ltd.
• 14.9. Koninklijke Philips N.V.
• 14.10. Yangzhou Kindsway Biotech Co. Ltd.
• 14.11. Shanghai United Imaging Healthcare Co Ltd.
• 14.12. Positron Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

15. Strategic Recommendations

16. About Us & Disclaimer